Danaher Corporation
Marktkapitalisierung
$142.4B
Globaler Rang
#120
Allzeithoch
$202.0B
2021-12-31
Gesamtwachstum
+0%
seit 2026
Market Cap Context
- Larger than 67% of the 367 companies we track (globally).
- Equivalent to 0.5% of United States's GDP (2025 data).
- Just above: #119 Iberdrola, S.A. ($145.1B)
- Just below: #121 Keyence ($141.0B)
- Best year: 2016 (+73%). Worst year: 2008 (-35%).
Danaher Corporation Financial Breakdown (FY 2025)
Source: Yahoo Finance — DHR annual filings (2025) →$24.6B revenue · $4.7B operating income · $3.6B net income
- ●Operating margin: 19.1% on $24.6B in revenue.
- ●R&D is 6.5% of revenue ($1.6B).
- ●Net income margin: 14.7% — $3.6B in profit.
- ●Free cash flow: $5.3B (21.4% of revenue).
Cost / Operating Expenses
Total operating expenses $19.9B
Total
$19.9B
Capital Expenditures
$1.2B
This fiscal year (near-total AI infrastructure buildout)
Free Cash Flow
$5.3B
Trailing twelve months
Figures rounded from the annual SEC filing. Unaudited. For informational purposes only, not investment advice.
Über Danaher Corporation
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing.
Verlauf der Marktkapitalisierung von Danaher Corporation (2026–2026)
Danaher Corporation vs Sector Peers by Market Cap
Danaher Corporation vergleichen
Rangverlauf
| Jahr | Marktkapitalisierung | Rang | Veränderung ggü. Vorjahr |
|---|---|---|---|
| 2026 | $142.4B | #120(↓23) | -11.8% |
| 2025 | $161.5B | #97(↓21) | +0.3% |
| 2024 | $160.9B | #76(↓15) | -0.4% |
| 2023 | $161.5B | #61(↓14) | -1.2% |
| 2022 | $163.5B | #47 | -19.0% |
| 2021 | $202.0B | #47(↑13) | +48.6% |
| 2020 | $136.0B | #60(↑13) | +45.4% |
| 2019 | $93.5B | #73(↑7) | +49.6% |
| 2018 | $62.5B | #80(↑21) | +11.8% |
| 2017 | $55.9B | #101(↓5) | +20.0% |
| 2016 | $46.6B | #96(↑56) | +73.0% |
| 2015 | $26.9B | #152(↑4) | +9.0% |
| 2014 | $24.7B | #156(↓11) | +11.5% |
| 2013 | $22.1B | #145(↑9) | +38.3% |
| 2012 | $16.0B | #154(↑3) | +19.1% |
| 2011 | $13.4B | #157(↑1) | -0.1% |
| 2010 | $13.5B | #158(↑13) | +25.7% |
| 2009 | $10.7B | #171(↓12) | +33.1% |
| 2008 | $8.0B | #159(↑6) | -35.4% |
| 2007 | $12.4B | #165(↑4) | +21.3% |
| 2006 | $10.3B | #169 | +30.0% |
| 2005 | $7.9B | #169(↓18) | -2.7% |
| 2004 | $8.1B | #151(↓1) | +25.3% |
| 2003 | $6.5B | #150(↑2) | +39.9% |
| 2002 | $4.6B | #152(↑17) | +9.1% |
| 2001 | $4.2B | #169(↓19) | -11.7% |
| 2000 | $4.8B | #150(↓14) | +41.9% |
| 1999 | $3.4B | #136(↓20) | -11.1% |
| 1998 | $3.8B | #116(↑12) | +72.3% |
| 1997 | $2.2B | #128(↓1) | +35.7% |
| 1996 | $1.6B | #127(↓1) | +47.2% |
| 1995 | $1.1B | #126(↓17) | +21.9% |
| 1994 | $908.1M | #109 |
Weitere Unternehmen im Sektor Gesundheitswesen
FAQ
What is Danaher Corporation's market cap?
Danaher Corporation (DHR) has a market capitalization of $142.4B, making it the #120 largest company in the world by market cap.
What was Danaher Corporation's highest market cap?
Danaher Corporation's all-time high market cap was $202.0B, reached in 2021-12-31. Its highest rank was #47 in 2021.
What sector is Danaher Corporation in?
Danaher Corporation is in the Healthcare sector, specifically the Diagnostics & Research industry. It is based in United States.
How has Danaher Corporation's market cap changed over time?
Danaher Corporation has been tracked since 2026. Its market cap has grown by 0% from $142.4B in 2026 to $142.4B today.